1. Home
  2. BBNX vs FTHY Comparison

BBNX vs FTHY Comparison

Compare BBNX & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • FTHY
  • Stock Information
  • Founded
  • BBNX 2015
  • FTHY 2020
  • Country
  • BBNX United States
  • FTHY United States
  • Employees
  • BBNX N/A
  • FTHY N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • FTHY Investment Managers
  • Sector
  • BBNX Health Care
  • FTHY Finance
  • Exchange
  • BBNX Nasdaq
  • FTHY Nasdaq
  • Market Cap
  • BBNX 463.4M
  • FTHY 500.1M
  • IPO Year
  • BBNX 2025
  • FTHY N/A
  • Fundamental
  • Price
  • BBNX $11.14
  • FTHY $13.79
  • Analyst Decision
  • BBNX Strong Buy
  • FTHY
  • Analyst Count
  • BBNX 6
  • FTHY 0
  • Target Price
  • BBNX $26.67
  • FTHY N/A
  • AVG Volume (30 Days)
  • BBNX 690.5K
  • FTHY 176.7K
  • Earning Date
  • BBNX 05-06-2025
  • FTHY 01-01-0001
  • Dividend Yield
  • BBNX N/A
  • FTHY 10.93%
  • EPS Growth
  • BBNX N/A
  • FTHY N/A
  • EPS
  • BBNX N/A
  • FTHY N/A
  • Revenue
  • BBNX $65,123,999.00
  • FTHY N/A
  • Revenue This Year
  • BBNX $29.49
  • FTHY N/A
  • Revenue Next Year
  • BBNX $34.93
  • FTHY N/A
  • P/E Ratio
  • BBNX N/A
  • FTHY N/A
  • Revenue Growth
  • BBNX 442.93
  • FTHY N/A
  • 52 Week Low
  • BBNX $8.89
  • FTHY $12.66
  • 52 Week High
  • BBNX $24.50
  • FTHY $14.74
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • FTHY 43.00
  • Support Level
  • BBNX N/A
  • FTHY $13.49
  • Resistance Level
  • BBNX N/A
  • FTHY $13.99
  • Average True Range (ATR)
  • BBNX 0.00
  • FTHY 0.35
  • MACD
  • BBNX 0.00
  • FTHY 0.00
  • Stochastic Oscillator
  • BBNX 0.00
  • FTHY 58.21

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.

Share on Social Networks: